Dr. Nimita Limaye leads R&D Strategy and Technology at IDC Health Insights, providing research-based advisory and consulting services on the Life Sciences industry. She represents Healthcare and life science on IDC's AI Council. She is an executive business leader with more than two decades of life sciences leadership experience in the pharma/CRO/tech consulting industry. She focuses on the role of data and technology in transforming drug development, RWD, synthetic data and analyzing and predicting evolving trends in the life sciences industry. Nimita was the chair of the SCDM board, chaired several conferences roundtables, given keynote talks, participated in fireside chats, and authored close to a 100 thought leadership papers.

Bindu Narang heads the Aggregate Safety, Signalling and Risk Management Practice at Labcorp Drug Development. A pharmacist by qualification (post grad degree in Medicinal Chemistry) with 19 years supporting biopharma regulatory medical writing and 10 years in medical affairs/ marketing roles, Bindu has significant leadership experience, set-up regulatory, medical communications and regulatory operations; managed teams in Labelling, Medical Information, Aggregate Safety, Signal and Risk Management. Among key accomplishments, there’s setting up of a global medical writing team for Pfizer Global R&D’s Development Operations in 2004, and growing a Safety and Medical Writing practise for Sciformix in 2012.

Mark's law practice at Ropes & Gray focuses on human and animal research, stem cell and genetic research, research grants and contracts, research fraud, and international research. Mark formerly served at Harvard as the Senior Associate Provost for Research, and in 2004 started and directed for several years Harvard's HIV/AIDS treatment programs in Nigeria, Tanzania and Botswana. He has served as chief administrative officer at St. Jude Children’s Research Hospital, and has held senior appointed positions in the New York City and State departments of health. Mark is co-chair of the Subcommittee on Harmonization of Research Regulations, HHS Secretary’s Advisory Committee on Human Subjects Protections.

Dr. Preeti Verma is an MS in OBG with over 15 years of experience in Medicine and PVG. She is Head of Operations and Delivery,drug safety, MICC and regulatory affairs.Prior, to this, she was she Associate Vice President, Pharmacovigilance Operations at APCER.She has experience in ICSR processing/Signal Management/Aggregate Report/quality management/handling audits&inspections exhibiting rapid progression for excellence,process implementation/improvements/transition and driving innovation. In her corporate career, she has been associated with various therapeutic areas as Dermatology,Endocrinology,Neurology&Respiratory diseases.

Dr. Bobby George is Vice President & Group Head of Regulatory Affairs at Reliance Life Sciences, Mumbai. He holds Masters and Ph.D. in Pharmacology from Panjab University, Chandigarh. He has also completed Senior Management Program from IIM, Kozhikode. He has over 25 years of industrial experience. He has been with Reliance Life Sciences for over 2 decades now. At Reliance, he is responsible for all their regulatory services across Pharmaceuticals, Biosimilars, Blood products and Vaccines in both domestic and export markets. He has to his credit several publications including a book which he authored on healthcare laws and reforms called “The Act that Wasn’t”.